Aurinia Pharmaceuticals Inc. (FRA:IKAP)
13.76
+0.26 (1.89%)
At close: Dec 19, 2025
Aurinia Pharmaceuticals Employees
Aurinia Pharmaceuticals had 130 employees as of December 31, 2024. The number of employees decreased by 170 or -56.67% compared to the previous year.
Employees
130
Change (1Y)
-170
Growth (1Y)
-56.67%
Revenue / Employee
€1,742,678
Profits / Employee
€510,311
Market Cap
1.82B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 130 | -170 | -56.67% |
| Dec 31, 2023 | 300 | 0 | - |
| Dec 31, 2022 | 300 | 0 | - |
| Dec 31, 2021 | 300 | 6 | 2.04% |
| Dec 31, 2020 | 294 | 232 | 374.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Deutsche Post AG | 573,964 |
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
Aurinia Pharmaceuticals News
- 18 days ago - AUPH Sees Downgrade by Leerink Partners as Price Target is Raised | AUPH Stock News - GuruFocus
- 19 days ago - Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - The Motley Fool
- 19 days ago - Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Nasdaq
- 27 days ago - First Week of AUPH July 2026 Options Trading - Nasdaq
- 5 weeks ago - FDA Appointment Boosts Aurinia Pharma (AUPH) and Biotech Stocks - GuruFocus
- 6 weeks ago - Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Nasdaq
- 6 weeks ago - Jefferies Upgrades Aurinia Pharmaceuticals (AUPH) to Buy, Raises Price Target | AUPH Stock News - GuruFocus
- 6 weeks ago - AUPH: RBC Capital Downgrades Aurinia Pharmaceuticals, Raises Price Target | AUPH Stock News - GuruFocus